Carna Biosciences, Inc. — Investor Relations & Filings
Carna Biosciences, Inc. is a clinical-stage biopharmaceutical company specializing in the discovery and development of small molecule kinase inhibitors. The company focuses on creating therapies for diseases with significant unmet medical needs, particularly in oncology and autoimmune disorders. Carna Biosciences operates through two core segments: a drug discovery business that advances its proprietary pipeline of drug candidates, and a drug discovery support business. The support division provides the global research community with a comprehensive portfolio of products and services, including a wide array of kinase proteins, biochemical and cell-based screening, and profiling services to accelerate pharmaceutical research and development.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| docirbrutinib（AS-1763）開発促進新株予約権（行使価額修正条項付）の月間行使状況に関するお知らせ | 2026-06-01 | Japanese | |
| 従業員に対する譲渡制限付株式としての新株式発行の払込完了に関するお知らせ | 2026-05-13 | Japanese | |
| 営業外費用及び特別損失の計上に関するお知らせ | 2026-05-08 | Japanese | |
| 2026年第1四半期決算説明資料 | 2026-05-08 | Japanese | |
| 2026年12月期第１四半期決算短信〔日本基準〕(連結) | 2026-05-08 | Japanese | |
| 従業員に対する譲渡制限付株式としての新株式発行に関するお知らせ | 2026-04-16 | Japanese |
Browse filings by year
12 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
10 filings
| |||||
| 47912520 | docirbrutinib（AS-1763）開発促進新株予約権（行使価額修正条項付）の月間行使状況に関するお知らせ | 2026-06-01 | Japanese | ||
| 46884290 | 従業員に対する譲渡制限付株式としての新株式発行の払込完了に関するお知らせ | 2026-05-13 | Japanese | ||
| 46881913 | 営業外費用及び特別損失の計上に関するお知らせ | 2026-05-08 | Japanese | ||
| 46881911 | 2026年第1四半期決算説明資料 | 2026-05-08 | Japanese | ||
| 46881910 | 2026年12月期第１四半期決算短信〔日本基準〕(連結) | 2026-05-08 | Japanese | ||
| 46877347 | 従業員に対する譲渡制限付株式としての新株式発行に関するお知らせ | 2026-04-16 | Japanese | ||
| 33044091 | 確認書 | 2026-03-26 | Japanese | ||
| 33044089 | 有価証券報告書－第23期(2025/01/01－2025/12/31) | 2026-03-26 | Japanese | ||
| 19421838 | 訂正有価証券届出書（組込方式） | 2026-02-10 | Japanese | ||
| 13645575 | 有価証券届出書（組込方式） | 2026-01-29 | Japanese | ||
|
2025
5 filings
| |||||
| 8199625 | 訂正有価証券届出書（組込方式） | 2025-11-11 | Japanese | ||
| 7855876 | 訂正有価証券届出書（組込方式） | 2025-09-12 | Japanese | ||
| 7859020 | 訂正有価証券届出書（組込方式） | 2025-08-07 | Japanese | ||
| 7859019 | 訂正有価証券届出書（組込方式） | 2025-08-07 | Japanese | ||
| 7859017 | 確認書 | 2025-08-07 | Japanese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Abliva
Biopharmaceutical company developing medicines for primary …
|
ABLI | SE | Manufacturing |
|
AB Science
Researches and develops protein kinase inhibitors for human…
|
AB | FR | Manufacturing |
|
ABVC BIOPHARMA, INC.
Develops botanical drugs and medical devices for oncology, …
|
ABVC | US | Manufacturing |
|
ACADIA PHARMACEUTICALS INC
Biopharmaceutical company developing medicines for CNS diso…
|
ACAD | US | Manufacturing |
|
Access Bio, Inc.
Develops and manufactures in vitro diagnostic solutions for…
|
950130 | IN | Manufacturing |
|
Accretion Nutraveda Limited
Develops and manufactures pharmaceutical, nutraceutical, an…
|
544694 | IN | Manufacturing |
|
Accretion Pharmaceuticals Limited
Develops and manufactures therapeutic formulations across d…
|
ACCPL | IN | Manufacturing |
|
Acerus Pharmaceuticals Corporation
Specialty pharmaceutical company focused on developing and …
|
ASPCF | CA | Manufacturing |
|
ACHIEVE LIFE SCIENCES, INC.
A late-stage pharmaceutical company developing a treatment …
|
ACHV | US | Manufacturing |
|
Achyut Healthcare Limited
Procures, trades, and manufactures pharmaceutical APIs and …
|
543499 | IN | Manufacturing |
Carna Biosciences, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/11390/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=11390 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=11390 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=11390 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 11390}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Carna Biosciences, Inc. (id: 11390)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.